• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, July 14, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

O=MEGA23 and World Congress of Optometry combining for Southern Hemisphere’s biggest optical event

by Myles Hume
September 5, 2022
in Local, News
Reading Time: 6 mins read
A A
The largest optometry conference in the country, hosted in Melbourne, will consist of five concurrent streams.

The largest optometry conference in the country, hosted in Melbourne, will consist of five concurrent streams.

Share on FacebookShare on Twitter

Biennial event O=MEGA23 is hoping to showcase Australian optometry on the world stage through its partnership with the World Council of Optometry, as registration opens 12 months out from the event’s launch.

O=MEGA23, in partnership with the 4th World Congress of Optometry (WCO4), will be held in Melbourne from 8-10 September 2023, following a partnership between the Optical Distribution & Manufacturers Association of Australia (ODMA), Optometry Victoria South Australia (OV/SA) and the World Council of Optometry (WCO).

The joint event is expected to attract more than 2,000 global professionals, including optometrists, optical dispensers, ophthalmologists, orthoptists, ophthalmic nurses, practice staff, optical retailers and service providers, technicians and students over three days.

It’s being hailed as the largest optometric clinical conference and trade show in the Southern Hemisphere.

Keynote speaker announced

Mr James Wolffsohn, head of both the School of Optometry and Department of Audiology at the UK’s Aston University, has been announced as the O=MEGA23/WCO4 keynote speaker.

Having been a Clinical Research Fellow at the University of Melbourne, he has published more than 290 full peer-reviewed papers and presented at numerous international conferences. He is academic chair of the British Contact Lens Association and the International Myopia Institute’s chief scientific officer.

James Wolffsohn.

Wolffsohn’s main research areas are the development and evaluation of ophthalmic instrumentation, myopia management, contact lenses, intraocular lenses, and the tear film.

OV/SA CEO Ilsa Hampton was excited to welcome Wolffsohn back to Australia for the event.

“James Wolffsohn is a much-loved and internationally recognised speaker and we are honoured to have him present again in a city he’s so familiar with, having been a clinical research fellow here. At past events our members have described his presentations as thought-provoking and we’re sure his time at O=MEGA23/WCO4 will not disappoint,” she said.

Ilsa Hampton.

“We are putting together an exciting and educational program to go along with James’ presentation and we will open the call for abstracts in a month on 1 October.”

Program to cater for international audience

Professor Peter Hendicott, WCO president, said the opening of registrations was an important date for people from outside Australia wanting to attend the event.

“O=MEGA23/WCO4 is an opportunity for optometrists internationally to participate in what will be a high quality learning and professional development experience, and importantly, allows optometry to highlight its role in the international agenda of securing improved vision and eye health outcomes across the world,” he said.

Prof Peter Hendicott.

“We are encouraging those who would like to attend to secure their place by registering early, while those who would like to present at the event can apply through the call for abstracts process on the O=MEGA23/WCO4 website by 30 November. Poster abstracts will open in the new year.”

ODMA acting CEO Ms Amanda Trotman said both the trade fair and clinical conference will appeal to an international audience.

“This will be the largest eyewear and eyecare trade fair in Australia, featuring the latest technology, fashion, lenses, frames, equipment, instruments, and accessories,” she said.

“The event will also feature an accredited program, with exceptional learning opportunities from clinical speakers from around the world in a multi-stream format including keynote lectures, poster sessions and breakout sessions, along with a networking program,’ Amanda said.

Originally scheduled for 2021, the 4th World Congress of Optometry and O=MEGA21 were postponed due to the impact of COVID-19 travel restrictions. The 2023 event will mark the first major international gathering of eye health professionals in four years.

Early registration discounts will be offered until 30 April 2023. Learn more and register at www.omega-event.org

 More reading

OSHOW’s Sydney success could see event return to city for 2024

ODMA reviewing all options after tariff concession revoked

Related Posts

The capsule collection draws from Carrera’s historic colours – black, white and red. Image: Carrera.

Carrera celebrates milestone with limited-edition collection

by Rob Mitchell
July 14, 2026

To celebrate its 70th anniversary, Carrera has announced the introduction of an exclusive Made in Italy limited-edition capsule collection that...

Vision Eye Institute CEO Amanda Cranage (right) at Vision Hospital Group’s Boroondara Day Surgery. Images: VEI.

The hidden drivers of cataract success

by Helen Carter
July 14, 2026

It’s not just what happens under the surgical microscope that leads to strong cataract surgery outcomes. Many gains come from...

The runway concept evolved from a desire to reinvent a long-standing feature on the trade floor. Images: ODMA.

Runway spectacle for O-SHOW26

by Helen Carter
July 13, 2026

O-SHOW26 will turn up the fashion focus with its first ever runway parades to showcase frames in August. Event manager...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited